Preliminary Application of Precision Genomic Medicine Detecting Gene Variation in Patients with Multifocal Osteosarcoma
ConclusionsEarly and radical surgery accompanied by appropriate chemotherapy is the optimal means of treating MFOS. These patients may benefit from precision genomic medicine.
Source: Orthopaedic Surgery - Category: Orthopaedics Authors: Hao‐qiang Zhang, Ming‐hui Li, Peng Gao, Ping‐heng Lan, Bo Fan, Xin Xiao, Ya‐jie Lu, Guo‐jing Chen, Zhen Wang Tags: CLINICAL ARTICLE Source Type: research
More News: Biology | Bone Cancers | Chemotherapy | Genetics | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Orthopaedics | Osteosarcoma | Study